The importance of stromal and intratumoral tumor lymphocyte infiltration for pathologic complete response in patients with locally advanced breast cancer

Journal of Cancer Research and Therapeutics
Melek Karakurt EryilmazHasan Senol Coskun

Abstract

Increased tumor-infiltrating lymphocytes (TILs) in breast carcinoma tissues is an independent predictive factor for pathologic complete response (pCR). The increased intratumoral and stromal TILs (sTILs) in breast cancer (BC) have significant prognostic effects. In this study, we evaluated whether pCR rates to neoadjuvant chemotherapy (NACT) are higher in tumors with increased number of TILs in the pretreatment biopsy. We retrospectively evaluated the number of TILs in intratumoral TILs (iTILs) and sTILs compartments from pretreatment full-face hematoxylin and eosin-stained sections of 62 patients with locally advanced BC (LABC) who received NACT. The capacity of sTILs and iTILs in predicting pCR to NACT in LABC analyzed using receiver operating characteristic (ROC) curve analysis. According to ROC curve analysis, the optimum sTILs and iTILs cut-off points (the number of positive cells per square millimeter of tissue) for patients with LABC patients with pCR (+) were 19 (area under the curve (AUC): 0.668, 95% confidence interval [CI] [0.501-0.835],P = 0.064) and 4 (AUC: 0.786, 95%CI [0.666-0.907],P = 0.002), respectively. Of the 62 patients, 26 had sTILs >19 and 25 had iTILs >4. The patients were divided into two according to p...Continue Reading

References

Oct 3, 1990·Journal of the National Cancer Institute·G BonadonnaF Rilke
Jan 1, 1994·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S VesalainenK Syrjänen
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Oct 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco ColleoniAron Goldhirsch
Dec 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo CristofanilliG N Hortobagyi
Apr 12, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry D BearNorman Wolmark
Feb 9, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Priya RastogiNorman Wolmark
Mar 4, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andrea MerloAndrea Balsari
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carsten DenkertGunter von Minckwitz
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Jun 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laura J EssermanNola Hylton
Mar 13, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Sherene LoiChristos Sotiriou
Mar 22, 2014·Molecular and Clinical Oncology·Miki TakenakaMasayoshi Kage
Apr 20, 2014·Journal of breast cancer·Kwan Il KimHeung Kyu Park
Jul 30, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sylvia AdamsSunil S Badve
Oct 24, 2014·Oncoimmunology·Yasmin Issa-NummerCarsten Denkert
Nov 2, 2014·Breast Cancer Research and Treatment·Ezzeldin M IbrahimGhieth A Kazkaz
May 23, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M V DieciA Goubar
Oct 16, 2015·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·X YuJ Huang

Related Concepts

Antineoplastic Chemotherapy Protocols
Mammary Neoplasms, Human
Neoplasm Invasiveness
Retrospective Studies
Receiver Operating Characteristic
Lymphocytes, Tumor-Infiltrating
Chemotherapy, Adjuvant
Stromal Cells
Mammary Ductal Carcinoma
Neoadjuvant Therapy

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.